<DOC>
	<DOCNO>NCT00211510</DOCNO>
	<brief_summary>The purpose study determine whether Type 1 Diabetic subject use Paradigm 722 System , glucose sensor-augmented insulin pump , improve glycemic control compare subject use Paradigm 715 insulin pump .</brief_summary>
	<brief_title>Use Paradigm 722 System Improve Glycemic Control Adult Adolescent Subjects With Type 1 Diabetes</brief_title>
	<detailed_description>Glycemic control remain significant challenge adult adolescent Type 1 diabetic . Continuous Glucose Monitoring ( CGMS ) currently use clinician record continuous , retrospective glucose measurement aid identification glycemic excursion pattern . This data use make therapy change recommendation future . The Paradigm 722 System transmit real-time glucose measurement insulin pump every 5 minute , allow user view current glucose value , well review glycemic excursion trend 24-hour period . This System alert user high low glucose level , allow subject clinicians treat therapeutic target HbA1c monitor condition . Subjects wear Paradigm 722 System compare subject wear Paradigm 715 Insulin Pump 6 month period evaluate change glycemic control ( HbA1c ) .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Age 12 80 year Type 1 Diabetes Mellitus diagnose least 1 year ago Using insulin infusion pump past 6 month minimum Performing minimum 4 blood glucose test per day Agree treat A1c target Read understand English Pregnant plan pregnancy History unresolved tape allergy skin condition</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>Diabetes</keyword>
	<keyword>Continuous Glucose Monitoring</keyword>
	<keyword>Glycemic Control</keyword>
</DOC>